A phase 1, dose-escalation, double-blind, block-randomized, controlled trial of safety and efficacy of neosaxitoxin alone and in combination with 0.2 % bupivacaine, with and without epinephrine, for cutaneous anesthesia - Lobo, K; Donado, C; Cornelissen, L (Anesthesiology, 2015)
et al.